COVID-19 Could Offer Some DSCSA Enforcement Relief For Manufacturers

As the US FDA focuses on COVID-19 pandemic-related activities, the time may be right to ask for an extension in complying with the DSCSA’s saleable returns verification deadline.

Coronavirus
Coronoavirus Consumes Much Of FDA's DSCSA Enforcement Focus For Now • Source: Shutterstock

Now may be a good time for manufacturers to seek a delay in the US Food and Drug Adminstration's enforcement of a provision in the Drug Supply Chain Security Act that requires setting up verification return systems by this November, given the agency's need to devote significant attention to COVID-19 pandemic-related activities.

That's the conclusation of Tish Eggleston Pahl, a principal attorney with the Washington food and drug law firm Olsson Frank...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Compliance